Ceftazidime Kabi

Ceftazidime Kabi is an intravenous antibiotic used to treat bacterial infections. This medication, manufactured by Fresenius Kabi Polska, is effective against a range of gram-negative bacteria.

Ceftazidime Kabi is primarily used for the treatment of bacterial infections, including those caused by gram-negative bacteria. It is often prescribed for infections in the lungs, urinary tract, and skin. Ceftazidime is also used to treat infections in patients with weakened immune systems. The medication works by stopping the growth of bacteria, helping the body to fight off infections.

Common effects of Ceftazidime Kabi may include mild to moderate reactions at the injection site, such as redness or swelling. Some patients may experience nausea, diarrhea, or headache. These effects are usually temporary and resolve on their own. If severe or persistent, consult a healthcare professional.

Ceftazidime Kabi should be used with caution in patients with a history of allergic reactions to cephalosporin antibiotics. It is important to inform your healthcare provider about any allergies or medical conditions before starting treatment. The medication should be administered under the supervision of a healthcare professional to ensure proper dosage and administration.

Ceftazidime Kabi may interact with certain medications, including other antibiotics and diuretics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication, as it may increase the risk of side effects.